All News

Musella’s plan for the Brain Tumor Virtual Trial Registry is to get patients access to more drugs at a faster pace, while collecting treatment and efficacy information that can later be used by oncologists across the country to treat others.

Remission may put an end to the disease, but it does not always stop the feeling of being lost.

There are a host of treatments available for non-small cell lung cancer (NSCLC) these days, and for patients, perhaps the most crucial step in choosing one is to make sure a pathologist genetically sequences the tumor, so that doctors will know which mutations are driving the cancer.

Checkpoint inhibitors continue to show promise in the treatment of patients with non-small cell lung cancer (NSCLC), but researchers are now exploring the efficacy of these agents when combined with radiation therapy (RT).

A breast cancer survivor ponders the dangers in a drink.

A young cancer survivor shares insight on what it was like being diagnosed with non-Hodgkin lymphoma, and how she deals in day-to-day life.

A group of researchers are working to determine whether more of these melanomas would be detected, and diagnosed earlier, if hairdressers were taught to recognize them.

A study published in the Journal of the American Academy of Dermatology evaluated the impact of time between melanoma diagnosis and surgery on the survival of people with stage 1 to stage 3 cutaneous melanoma.

The Rapunzel Project is dedicated to spreading the word about hair-preserving treatments for patients undergoing chemotherapy.

When combined with other regimens in the treatment of patients with bladder cancer, immunotherapy has been shown to be beneficial, according to Arjun Balar, M.D.

Christmas can be a real challenge when going through cancer. Aside from the financial burden that may limit the number of boxes under the tree, the emotional burden can dampen what is usually a happy and cheerful time of year.

The variety of treatment options now available for non-small cell lung cancer (NSCLC) — including checkpoint inhibitors and targeted therapies — presents challenges in choosing the right treatment plan.

My sister was told about hair loss many times at the beginning of treatment, but the magnitude of being bald didn't hit her until the hair started coming out.

Breast cancer survivor thinks through her decision about a prophylactic double mastectomy after new genetic test results show a significant risk of recurrence.

The CLL Society is a nonprofit organization that serves the CLL community by offering a platform for patients and caregivers to receive education and support, as well as information on cutting-edge research and treatment options.

If you are into giving gifts possibly consider giving yourself the gift of wellness by seeing a nutritionist before the year is over or to begin 2018 in a good direction.

While patients with chronic lymphocytic leukemia (CLL) tend to have long life expectancies, with many prescribed to a “watch-and-wait” approach, a recent study by the Cancer Support Community (CSC) found that more than half of patients living with the disease reported that having CLL affects their viewpoints regarding their life expectancy.

Not all employees with cancer get paid leave, but those who did saw better health and financial outcomes.

Malnutrition is common in patients with cancer, but there are steps that can be taken to avoid it.

A four-drug combination, including Tecentriq (atezolizumab), Avastin (bevacizumab), carboplatin and paclitaxel, delayed progression or death by 38 percent in patients with advanced non-squamous non–small cell lung cancer (NSCLC), compared to those who were treated with Avastin alone.

Approximately 420,000 Americans are adult survivors of childhood cancer, and these individuals may be twice as likely to have high blood pressure, also known as hypertension, according to researchers at St. Jude Children’s Research Hospital.

Of course, there was sadness, but more than anything there was appreciation for my own life and the people close to me. I feel gratitude for still being here, having an excellent quality of life and for the warning cancer gives.

The FDA has approved a novel breast-specific stereotactic body radiotherapy (SBRT) device known as GammaPod as a treatment for patients with breast cancer, based on findings from a 17-patient study.

After breast cancer surgery and lymph node removal, I developed lymphedema, a painful, lifelong condition. This medical problem is often misunderstood but is it my place to help bring awareness? One survivor speaks out.

Although ROS1 mutations are quite rare in patients with non-small cell lung cancer (NSCLC), testing for the mutation in all who have the disease is important, as it can play a vital role in determining a treatment plan.

Life goes on after a cancer diagnosis, but it's never quite the same.

Imfinzi (durvalumab), a PD-L1 inhibitor, is being reviewed for a supplemental biologics license application (sBLA) by the Food and Drug Administration (FDA) for the treatment of patients with stage 3, unresectable non-small cell lung cancer (NSCLC). The sBLA is in light of positive progression-free survival (PFS) results from the phase 3 PACIFIC trial.

A very light hearted look at a serious problem.

The Food and Drug Administration (FDA) has granted a priority review to a supplemental new drug application (sNDA) for the use of Tafinlar (dabrafenib) combined with Mekinist (trametinib) as an adjuvant treatment for patients with BRAFV600E– or V600K–positive stage 3 melanoma following complete resection.

The liver cancer treatment field has remained stagnant for years, but new agents are destined to enter the field in the near future, Ghassan K. Abou-Alfa, M.D., says.